SIRNAOMICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.65 HKD | +5.37% |
|
+1.06% | -78.63% |
| 05-10 | Sirnaomics Ltd. Appoints Edward Yongxiang Wang as Executive Director | CI |
| 04-17 | Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 8.200 | 15.26 | 18.45 |
| Spread/Res. | -6.71% | -49.87% | -58.54% |
| Spread/Supp. | +31.90% | +31.90% | +31.90% |
| Support | 5.800 | 5.800 | 5.800 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 2257 Stock
- Charts Sirnaomics Ltd.
